Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (11-20 of 458) with videos related to

Pageof 46
Sort By:
Molecular Oncology|December 14, 2020
Refining immunotherapeutic approaches to high-risk neuroblastoma based on tumor genomic profilesLiron D Grossmann, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcomeKristina A Cole, John M Maris
Nature Reviews. Cancer|February 18, 2015
Revisiting tissue specificity of germline cancer predisposing mutationsJohn M Maris, Alfred G Knudson
International Journal of Pediatric Otorhinolaryngology|May 21, 2011
Auditory neuropathy/dyssynchrony as a cause of failed neonatal hearing screeningM Maris, C Venstermans, A N Boudewyns
Medical and Pediatric Oncology|December 7, 2000
Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470S Shusterman, S A Grupp, J M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Inhibition of ALK signaling for cancer therapyYael P Mossé, Andrew Wood, John M Maris
Current Opinion in Genetics & Development|May 2, 2017
Genetic susceptibility to neuroblastomaVanessa P Tolbert, Grace E Coggins, John M Maris
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug DevelopmentGregory Reaman, Louis Stancato, Gilles Vassal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaErik Fredlund, Markus Ringnér, John M Maris, et al.
The Journal of Pediatrics|February 1, 1995
Loss of detectable antibody to hepatitis B surface antigen in immunized patients with hemophilia but without human immunodeficiency virus infectionJ M Maris, R B Butler, A R Cohen
Pageof 46

Showing results (11-20 of 458) with videos related to

Sort By:
Pageof 46
Molecular Oncology|December 14, 2020
Refining immunotherapeutic approaches to high-risk neuroblastoma based on tumor genomic profilesLiron D Grossmann, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcomeKristina A Cole, John M Maris
Nature Reviews. Cancer|February 18, 2015
Revisiting tissue specificity of germline cancer predisposing mutationsJohn M Maris, Alfred G Knudson
International Journal of Pediatric Otorhinolaryngology|May 21, 2011
Auditory neuropathy/dyssynchrony as a cause of failed neonatal hearing screeningM Maris, C Venstermans, A N Boudewyns
Medical and Pediatric Oncology|December 7, 2000
Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470S Shusterman, S A Grupp, J M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Inhibition of ALK signaling for cancer therapyYael P Mossé, Andrew Wood, John M Maris
Current Opinion in Genetics & Development|May 2, 2017
Genetic susceptibility to neuroblastomaVanessa P Tolbert, Grace E Coggins, John M Maris
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug DevelopmentGregory Reaman, Louis Stancato, Gilles Vassal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaErik Fredlund, Markus Ringnér, John M Maris, et al.
The Journal of Pediatrics|February 1, 1995
Loss of detectable antibody to hepatitis B surface antigen in immunized patients with hemophilia but without human immunodeficiency virus infectionJ M Maris, R B Butler, A R Cohen
Pageof 46